Explore FHI 360

Published research

Expanding equity measurements of family planning beyond wealth status and contraceptive use

Tools

Market Development and Product Introduction (fact sheet)

This factsheet offers a high-level overview of the current work of FHI 360’s Market Development and Product Introduction initiative.

Feature

Adaptive management improves and enables effective social and behavior change programming

FHI 360 uses an adaptive management approach to improve integrated social and behavior change programming in Tanzania through the USAID Tulonge Afya project.

News

New contraceptive technology project will expand family planning options

Innovate FP will expand desirable, low-cost, quality contraceptive options to enable women to better meet their changing needs and desires throughout their reproductive lives.

Project

Innovate FP: Expanding Options, Enhancing Method Choice

Innovate FP is a contraceptive research project to expand desirable, affordable, quality contraceptive options to better meet the needs of women.

Event

International Conference on Family Planning: #NextGenFP and FHI 360

At the 2018 International Conference on Family Planning, FHI 360 shares results from our latest research, programs, innovative interventions and digital technologies.

Feature

Removing cost and access barriers to contraceptive implants (audio)

Markus Steiner and Kate Rademacher of FHI 360 discuss the long-term effort to increase global access to contraceptive implants at an affordable price.

Published research

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

The authors found that women who self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) led to a more than 50 percent increase in pregnancy protection through 12 months compared with provider-administered injection. The findings demonstrate that self-injection can address the stubborn problem of early contraceptive discontinuation and that community health workers can safely train women to self-inject. Malawi plans to introduce DMPA-SC self-injection based on these positive findings.

Publication

Postpartum Family Planning: New Research Findings and Program Implications

July 2012 — FHI 360 and the U.S. Agency for International Development (USAID) invited key partners to attend a series of end-of-project meetings convened by the Program Research for Strengthening Services (PROGRESS) project, a five-year...

Tools

Family Health Research Newsletters

Family Health Research is a newsletter designed to promote the use of evidence-based practices in reproductive health programs. Each issue examines a key topic in reproductive health care — offering the latest updates on innovative research...

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Expanding equity measurements of family planning beyond wealth status and contraceptive use

Market Development and Product Introduction (fact sheet)

Adaptive management improves and enables effective social and behavior change programming

New contraceptive technology project will expand family planning options

Innovate FP: Expanding Options, Enhancing Method Choice

International Conference on Family Planning: #NextGenFP and FHI 360

Removing cost and access barriers to contraceptive implants (audio)

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

Postpartum Family Planning: New Research Findings and Program Implications

Family Health Research Newsletters

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

10 Results Found

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial